On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

Matteo Cesari; Riccardo Calvani; M. Canevelli; I. Aprahamian; P. De Souto Barreto; D. Azzolino; R. A. Fielding; N. Vanacore; M. Inzitari; Emanuele Marzetti

doi:10.14283/jfa.2021.23

On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

Matteo Cesari, Riccardo Calvani, M. Canevelli, I. Aprahamian, P. De Souto Barreto, D. Azzolino, R. A. Fielding, N. Vanacore, M. Inzitari, Emanuele Marzetti

Risultato della ricerca: Contributo in rivista › Editoriale in rivista / quotidiano

Abstract

From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised significant issues in the field of research. The investigators’ responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).

Lingua originale	English
pagine (da-a)	310-312
Numero di pagine	3
Rivista	THE JOURNAL OF FRAILTY & AGING
Volume	10
DOI	https://doi.org/10.14283/jfa.2021.23
Stato di pubblicazione	Pubblicato - 2021

Keywords

COVID-19
Humans
Pandemics
Research
SARS-CoV-2
medicine
methodology
publishing
science

Accesso al documento

10.14283/jfa.2021.23

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{3cee22d484654365ab654ffb0afab127,

title = "On Schr{\"o}dinger{\textquoteright}s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal",

abstract = "From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised significant issues in the field of research. The investigators{\textquoteright} responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).",

keywords = "COVID-19, Humans, Pandemics, Research, SARS-CoV-2, medicine, methodology, publishing, science, COVID-19, Humans, Pandemics, Research, SARS-CoV-2, medicine, methodology, publishing, science",

author = "Matteo Cesari and Riccardo Calvani and M. Canevelli and I. Aprahamian and {De Souto Barreto}, P. and D. Azzolino and Fielding, {R. A.} and N. Vanacore and M. Inzitari and Emanuele Marzetti",

year = "2021",

doi = "10.14283/jfa.2021.23",

language = "English",

volume = "10",

pages = "310--312",

journal = "THE JOURNAL OF FRAILTY & AGING",

issn = "2260-1341",

publisher = "Auzeville (43 chemin Del Prat ; 31320) : SERDI, 2012-",

}

TY - JOUR

T1 - On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

AU - Cesari, Matteo

AU - Calvani, Riccardo

AU - Canevelli, M.

AU - Aprahamian, I.

AU - De Souto Barreto, P.

AU - Azzolino, D.

AU - Fielding, R. A.

AU - Vanacore, N.

AU - Inzitari, M.

AU - Marzetti, Emanuele

PY - 2021

Y1 - 2021

N2 - From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised significant issues in the field of research. The investigators’ responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).

AB - From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised significant issues in the field of research. The investigators’ responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).

KW - COVID-19

KW - Humans

KW - Pandemics

KW - Research

KW - SARS-CoV-2

KW - medicine

KW - methodology

KW - publishing

KW - science

KW - COVID-19

KW - Humans

KW - Pandemics

KW - Research

KW - SARS-CoV-2

KW - medicine

KW - methodology

KW - publishing

KW - science

UR - http://hdl.handle.net/10807/200985

U2 - 10.14283/jfa.2021.23

DO - 10.14283/jfa.2021.23

M3 - Editorial

SN - 2260-1341

VL - 10

SP - 310

EP - 312

JO - THE JOURNAL OF FRAILTY & AGING

JF - THE JOURNAL OF FRAILTY & AGING

ER -

On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo